News Column

ARIAD PHARMACEUTICALS INC FILES (8-K) Disclosing Other Events, Financial Statements and Exhibits

June 19, 2014

ITEM 8.01 Other Events.

On June 18, 2014, ARIAD Pharmaceuticals, Inc. (the "Company") sent a letter to Institutional Shareholder Services ("ISS") requesting that ISS reconsider its recommendation that the Company's stockholders vote against the following proposals in the Company's proxy statement for its 2014 annual meeting to be held on June 25, 2014, and providing additional information regarding these proposals: (i) the approval of the Company's Section 382 rights agreement, (ii) the approval of the Company's 2014 Long-Term Incentive Plan, and (iii) the approval, on an advisory basis, of the compensation of the Company's named executive officers as disclosed in the proxy statement. A copy of the letter is attached hereto as Exhibit 99.1 and is incorporated by reference into this Item 8.01 of this Current Report on Form 8-K.

ITEM 9.01 Financial Statements and Exhibits

(d) The following exhibits are filed with this report:

Exhibit Number Description 99.1 Letter to Institutional Shareholder Services dated June 18, 2014 2


For more stories on investments and markets, please see HispanicBusiness' Finance Channel

Source: Edgar Glimpses

Story Tools Facebook Linkedin Twitter RSS Feed Email Alerts & Newsletters